BCIQ Profiles

Company Profile Report

Milestone raises $80M to fund pivotal trial of at-home tachycardia therapy

Milestone Pharmaceuticals Inc. (Montreal, Quebec) raised $80 million in a series D on Oct. 25 to support a Phase III trial of its self-administered acute paroxysmal supraventricular

Read the full 277 word article

How to gain access

Continue reading with a
two-week free trial.